Compound NH125 was able to inhibit eEF2K kinase activity remarkably, with in vitro IC50 of 60 nM, in addition to glioma cell line experiments where NH125 treatment provided 10-fold resistance when eEF2K was overexpressed (Figure 1). The gene discussed is EEF2K; the disease is central nervous system cancer.